Summary
- Current Price
- As of today, MANE price is $110.57, up +3.20% in the most recent trading session on
- Current Price All-Time High
- MANE price is currently -6.07% below its historical high of $117.71 set on
- Market Cap
- MANE current market cap is $5B, with unknown 1-year change
- PE Ratio
- MANE PE ratio is unknown
- Revenue
- MANE current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for MANE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Veradermics, Incorporated |
| Ticker | NYSE: MANE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | veradermics.com |
| Employees | 21 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $110.57 | |
| Price, 1D Change | +3.20% | |
| $5B | ||
| - | ||
| - | ||
| 0.51 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.23 | ||
| EPS, 1Y Change | -186.84% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.23 | ||
| EPS Estimate | N/A | -$2.60 |
| EPS Est. Change | N/A | -16.28% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $110.57 | |
| Price Target | - | $120.00 |
| Price Tgt. Change | - | +8.53% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.17 | -$2.23 | -3.04% | |
| -$2.60 | N/A | -16.28% | |
| -$3.00 | N/A | -34.45% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| $12.99M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $110.57 | |
| $65.25 | ||
| SMA 200 vs Price | -40.99% | |
| $73.56 | ||
| SMA 50 vs Price | -33.48% | |
| 0.51 | ||
| $8.42 | ||
| 64.79 | ||
| 76.18% | ||
| 119.32% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.23 | ||
| $0.00 | ||
| - | ||
| -$72.35M | ||
| - | ||
| -$70.00M | ||
| - | ||
| -$72.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 16.29 | ||
| 16.29 | ||
| - | ||
| - | ||
| 299.01 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -37.90 | ||
| -193.17 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$121.01M | ||
| $141.86M | ||
| $154.47M | ||
| $149.11M | ||
| $9.16M | ||
| $9.15M | ||
| $4,000.00 | ||
| $0.00 | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $70.00M | ||
| $72.35M | ||
| $0.00 | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$71.60M | ||
| -$118.86M | ||
| $159.14M | ||
| $24.00K | ||
| -$71.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| Leerink Partners | ||
| Jefferies | ||
| Citigroup | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with MANE
FAQ
What is the ticker symbol for Veradermics, Incorporated?
The ticker symbol for Veradermics, Incorporated is NYSE:MANE
Does Veradermics, Incorporated pay dividends?
No, Veradermics, Incorporated does not pay dividends
What sector is Veradermics, Incorporated in?
Veradermics, Incorporated is in the Healthcare sector
What industry is Veradermics, Incorporated in?
Veradermics, Incorporated is in the Biotechnology industry
What country is Veradermics, Incorporated based in?
Veradermics, Incorporated is headquartered in United States
When did Veradermics, Incorporated go public?
Veradermics, Incorporated initial public offering (IPO) was on February 4, 2026
Is Veradermics, Incorporated in the S&P 500?
No, Veradermics, Incorporated is not included in the S&P 500 index
Is Veradermics, Incorporated in the NASDAQ 100?
No, Veradermics, Incorporated is not included in the NASDAQ 100 index
Is Veradermics, Incorporated in the Dow Jones?
No, Veradermics, Incorporated is not included in the Dow Jones index
When does Veradermics, Incorporated report earnings?
The next expected earnings date for Veradermics, Incorporated is May 29, 2026
Data Sources & References
- MANE Official Website www.veradermics.com
- MANE Profile on Yahoo Finance finance.yahoo.com/quote/MANE
- MANE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mane